Bayer Cements Supplement Sales Gains From Initial COVID Boost

A year on from the start of the COVID-19 outbreak and a global rush for supplements, Bayer has cemented these sales gains with slight growth at its Nutritionals business in Q1.

Bayer cross
• Source: Shutterstock

COVID-19 sent its dietary supplement sales soaring but a year on Bayer has been able to solidify those initial gains by its Nutritionals franchise.

More from Earnings

More from Business

Ceres Pharma Grows In Belgium With Kela Acquisition

 
• By 

Deal for fellow Belgian firm Kela will bolster Ceres' consumer health offering in Europe with brands such as Folavit and Hyalo.

US Consumer Health People Moves: Perrigo Science And Haleon US Customer Chiefs, More

 

Volleyball great Gabby Reece promotes Stemregen Sport; eye care pharma Harrow changes scientific lead; sisters partner to launch Renew-V vaginal moisturizer; Haleon tabs former Unilever executive as chief customer officer; and former Bayer executive leads Perrigo’s expanded scientific office.

McGuffin Moving To Senior Advisor At AHPA After More Than 25 Years At Helm

 

AHPA’s significant legislative victories included enactment of Dietary Supplement and Nonprescription Drug Consumer Protection Act in 2006 to establish a serious adverse event reporting law for vitamin, mineral and supplement products.